Codex DNA, Inc. (DNAY)

2.4600 +0.3300 (+15.49%) As of 11:52AM EDT. Market open.

Codex DNA, Inc.

9535 Waples Street
Suite 100
San Diego, CA 92121-2993
United States
858 228 4115
https://codexdna.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 264

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Todd R. Nelson MBA, Ph.D.	Pres, CEO & Director	876.78k	N/A	1967
Ms. Jennifer Isacoff McNealey M.H.A.	Chief Financial Officer	417.44k	N/A	1973
Mr. Daniel G. Gibson Ph.D.	Chief Technology Officer	436.54k	N/A	1977
Mr. Eric Esser	Chief Operating Officer	N/A	N/A	N/A
Richard Lepke	Director of Investor Relations	N/A	N/A	N/A
Mr. Robert H. Cutler	Chief Legal Officer	N/A	N/A	1968
Ms. Laura B. Puga M.B.A.	VP of People & Culture	N/A	N/A	1980
Mr. Decky Goodrich M.B.A.	Sr. VP of Commercial Operations	N/A	N/A	N/A
Mr. Laurence Warden	Sr. VP of Engineering & Instrumentation	N/A	N/A	N/A
Mr. Dimas Jimenez M.B.A.	VP & Corp. Controller	N/A	N/A	1970

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Corporate Governance

Codex DNA, Inc.’s ISS Governance QualityScore as of June 1, 2022 is 7. The pillar scores are Audit: 9; Board: 5; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.